During the past decade, Woolfson Eye Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Woolfson Eye Institute" #1 sponsor was "Topcon Medical Systems, Inc." with 3 trials, followed by "Clinical Research Consultants, Inc." with 2 trials sponsored, "American Corneal Consultants" with 1 trials sponsored, "Case Western Reserve University" with 1 trials sponsored and "Cxlusa" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Woolfson Eye Institute" #1 collaborator was "Alcon Research" with 2 trials as a collaborator, "HumanOptics AG" with 1 trials as a collaborator, "Jaeb Center for Health Research" with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator and "Science in Vision" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Woolfson Eye Institute" are "Keratoconus" (2 trials), "Cornea Preservation Time" (1 trials), "Corneal Diseases" (1 trials), "Corneal Ectasia" (1 trials) and "Ectasia" (1 trials). Many other conditions were trialed in "Woolfson Eye Institute" in a lesser frequency.

Most popular intervention types in "Woolfson Eye Institute" are "Device" (6 trials), "Drug" (3 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Riboflavin" (3 trials), "VEGA UV-A Illumination System" (2 trials), "Artificial Iris (CustomFlex)" (1 trials), "CXLO Corneal Strengthening Solution and UVA Illumination Device" (1 trials) and "Cornea tissue transplant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Woolfson Eye Institute" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Woolfson Eye Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Woolfson Eye Institute, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Woolfson Eye Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".